Pacer Advisors
GTHX

Pacer Advisors’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History

Pacer Advisors’s Portfolio GTHX Stock Details GTHX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-3,366
Closed -$81K – 1574
2021
Q1 		$81K Sell
3,366
-710
-17% -$16.5K ﹤0.01% 1316
2020
Q4 		$73K Buy
4,076
+2,766
+211% +$41.3K ﹤0.01% 1389
2020
Q3 		$15K Buy
+1,310
New +$21.6K ﹤0.01% 1367
2018
Q4 		– Sell
-2,126
Closed -$111K – 1082
2018
Q3 		$111K Buy
+2,126
New +$116K ﹤0.01% 1081

Other funds holding GTHX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
LOAMS
Lombard Odier Asset Management (Switzerland) Petit-Lancy, Switzerland $2.63B AUM 31.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Pacer Advisors's GTHX Position: Q2 2021 in Review

Pacer Advisors sold out of G1 Therapeutics, Inc. Common Stock (GTHX) in Q2 2021, closing a stake of 3,366 shares — an estimated $81K sold.

Pacer Advisors first reported a position in GTHX in Q3 2018 and held it in 4 quarters. The position peaked at $111K in Q3 2018. 114 funds tracked by Wall St. Rank hold GTHX as of Q2 2021.

  • Pacer Advisors reported no remaining G1 Therapeutics, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Pacer Advisors sold 3,366 G1 Therapeutics, Inc. Common Stock shares in Q2 2021, an estimated $81K.
  • Pacer Advisors first reported a position in G1 Therapeutics, Inc. Common Stock in Q3 2018 and held it in 4 quarters.
  • Pacer Advisors's G1 Therapeutics, Inc. Common Stock position peaked at $111K in Q3 2018.
  • 114 funds tracked by Wall St. Rank held G1 Therapeutics, Inc. Common Stock as of Q2 2021.

Based on Pacer Advisors's 13F filing for Q2 2021, filed 21 Jul 2021.